Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Brain Research Bulletin
|
March 2, 2026
Calycosin Exerts Anti-Glioblastoma Effects by Inhibiting GPX-4 to Promote Oxidative Stress
Qin Wei, Kexin Yang, Zhaoyang Liu, et al.
Journal of Pharmaceutical Sciences
|
October 13, 2020
Improved Pharmacokinetic Characteristics of Ursolic Acid in Rats Following Intratracheal Instillation and Nose-Only Inhalation Exposure
Chang Ren, Dexuan Kong, Chen Ning, et al.
The Journal of Pharmacy and Pharmacology
|
November 16, 2019
Pulmonary delivery alters the disposition of raloxifene in rats
Ying Kong, Hui Cai, Han Xing, et al.
Biopharmaceutics & Drug Disposition
|
April 2, 2019
Mechanistic study of absorption and first-pass metabolism of GL-V9, a derivative of wogonin
Han Xing, Chang Ren, Ying Kong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 24, 2020
Structural optimization of HPMA copolymer-based dexamethasone prodrug for improved treatment of inflammatory arthritis
Zhenshan Jia, Gang Zhao, Xin Wei, et al.
Molecules (Basel, Switzerland)
|
April 25, 2019
An Investigation on Glucuronidation Metabolite Identification, Isozyme Contribution, and Species Differences of GL-V9 In Vitro and In Vivo
Han Xing, Dexuan Kong, Chen Ning, et al.
Pharmaceutical Research
|
November 13, 2021
Characterization of Preclinical Pharmacokinetic Properties and Prediction of Human PK Using a Physiologically Based Pharmacokinetic Model for a Novel Anti-Arrhythmic Agent Sulcardine Sulfate
Chang Ren, Yao Wang, Mei Zhang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
July 18, 2020
Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice
Xin Wei, Gang Zhao, Xiaobei Wang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Brain Research Bulletin
|
March 2, 2026
Calycosin Exerts Anti-Glioblastoma Effects by Inhibiting GPX-4 to Promote Oxidative Stress
Qin Wei, Kexin Yang, Zhaoyang Liu, et al.
Journal of Pharmaceutical Sciences
|
October 13, 2020
Improved Pharmacokinetic Characteristics of Ursolic Acid in Rats Following Intratracheal Instillation and Nose-Only Inhalation Exposure
Chang Ren, Dexuan Kong, Chen Ning, et al.
The Journal of Pharmacy and Pharmacology
|
November 16, 2019
Pulmonary delivery alters the disposition of raloxifene in rats
Ying Kong, Hui Cai, Han Xing, et al.
Biopharmaceutics & Drug Disposition
|
April 2, 2019
Mechanistic study of absorption and first-pass metabolism of GL-V9, a derivative of wogonin
Han Xing, Chang Ren, Ying Kong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 24, 2020
Structural optimization of HPMA copolymer-based dexamethasone prodrug for improved treatment of inflammatory arthritis
Zhenshan Jia, Gang Zhao, Xin Wei, et al.
Molecules (Basel, Switzerland)
|
April 25, 2019
An Investigation on Glucuronidation Metabolite Identification, Isozyme Contribution, and Species Differences of GL-V9 In Vitro and In Vivo
Han Xing, Dexuan Kong, Chen Ning, et al.
Pharmaceutical Research
|
November 13, 2021
Characterization of Preclinical Pharmacokinetic Properties and Prediction of Human PK Using a Physiologically Based Pharmacokinetic Model for a Novel Anti-Arrhythmic Agent Sulcardine Sulfate
Chang Ren, Yao Wang, Mei Zhang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
July 18, 2020
Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice
Xin Wei, Gang Zhao, Xiaobei Wang, et al.
Page
of 2